Standardizing postpartum depression screening in the ambulatory pediatric setting coupled with implementing a referral algorithm and referral guide can help more PPD cases be identified, further evaluated, and treated.
Implementing mental health services early on in pediatric oncology patients has significant benefits, as managing such distress before symptom severity worsens creates better short- and long-term outcomes.
A large number of non-pregnant women of child-bearing age have untreated depression.
Collaborative care intervention does not improve health in chronic heart failure, but alleviates depression and fatigueMarch 07, 2018
Collaborative Care to Alleviate Symptoms and Adjust to Illness, a collaborative care intervention combining symptom and psychosocial care, did not improve heart failure-specific health status in chronic heart disease, compared to usual care.
For major depressive disorder patients in remission, cognitive behavioral therapy is an effective intervention for relapse prevention at either short- or long-term follow-up.
The chances of starting treatment were doubled for patients under 44 years compared to patients older than 60.
The American Academy of Pediatrics has updated clinical practice guidelines to assist primary care clinicians in the management of adolescent depression.
Some of the most effective antidepressants included agomelatine, amitriptyline, escitalopram, and mirtazapine.
Chronicity of depression is associated with increased likelihood of failure along the continuum of HIV care.
Sertraline and group cognitive behavioral therapy have similar long-term antidepressant effects in the treatment of mild to moderate depression.
Depression less common in as family income increased and less common in non-Hispanic Asians.
Past epidemiological investigations resulted in inconsistent reports on the affiliation between antidepressants and the risk of ovarian cancer.
In patients undergoing TAVR or SAVR, approximately 1 in 3 had depressive symptoms at baseline and a higher risk of short-term and midterm mortality.
Depressive symptoms at the time of treatment planning can predict overall 2 year mortality in patients with head and neck cancer.
Researchers recommend 7 online tools and mobile apps to help healthcare professionals reduce stress, burnout, depression, and suicidal behaviors.
Positive emotions and low levels of depression after a cardiovascular disease (CVD) event are associated with low risk for mortality during a 15-year period.
Ranging definitions of anxiety associated with depression have caused variations in findings.
Dermatologists across Europe tend to underestimate mood disorders in their patients.
Relatively modest changes in population levels of exercise may have important public mental health beneﬁts and prevent a substantial number of new cases of depression.
Omega-3 supplementation in children with mood disorders is associated with decreased impairment in executive functioning.
Heart rate variability and specific inflammatory biomarkers can differentiate major depressive disorder from depression in bipolar disorder.
Venlafaxine was superior to lithium in reducing symptoms of both bipolar II, depression, and anxiety.
Youths receiving dual therapy for depression had the highest incidence of attempted suicide compared with those receiving monotherapy.
The US Food and Drug Administration has approved Abilify MyCite, which contains an ingestible sensor that records whether or not the medication was taken.
US Surgical residents have severe stress and high burnout levels during general training.
Mood, health-related QoL, and anxiety are not further improved by internet support group.
Men who identified as vegetarian had higher depression scores compared with non-vegetarians.
Depressive symptoms increase during the internship year for training physicians, with a greater increase among women.
A correlation was found between undertaking regular leisure-time exercise and reduced incidence of future depression but not anxiety.
Clinicians prescribing antidepressants may need to consider augmenting monotherapy with another agent.